Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotactic leukotrienes in psoriasis.

× No keyword cloud information.

10 in total

1. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.

Authors: H Kankaanranta; E Moilanen; H Vapaatalo
Journal: Inflammation Date: 1991-04 Impact factor: 4.092

2. Chemotactic lipoxygenase products in sera from patients with psoriasis.

Authors: K Fogh; T Ternowitz; K Kragballe; T Herlin
Journal: Arch Dermatol Res Date: 1986 Impact factor: 3.017

3. Detection of immunoreactive leukotrienes LTC4/D4 in skin-blister fluid after allergen testing in patients with late cutaneous reactions (LCR).

Authors: W Dorsch; J Ring; P C Weber; T Strasser
Journal: Arch Dermatol Res Date: 1985 Impact factor: 3.017

Review 4. Psoriasis: Past, Present, and Future.

Authors: Allison C Billi; Johann E Gudjonsson; John J Voorhees
Journal: J Invest Dermatol Date: 2019-11 Impact factor: 8.551

5. Cytochrome P-450-dependent production of chemotactic arachidonate metabolites from human neutrophils.

Authors: B M Czarnetzki; G Goerz; K Bolsen; H Merk
Journal: Arch Dermatol Res Date: 1984 Impact factor: 3.017

6. Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes.

Authors: J Grabbe; B M Czarnetzki; M Mardin
Journal: Arch Dermatol Res Date: 1984 Impact factor: 3.017

7. 12-Hydroxyeicosatetraenoic acid (12-HETE) is a chemotactic stimulus for epidermal cells.

Authors: R Hein; E Gross; T Ruzicka; T Krieg
Journal: Arch Dermatol Res Date: 1991 Impact factor: 3.017

8. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile.

Authors: F Grimminger; P Mayser; C Papavassilis; M Thomas; E Schlotzer; K U Heuer; D Führer; K D Hinsch; D Walmrath; W B Schill
Journal: Clin Investig Date: 1993-08

9. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.

Authors: R A Patrick; P A Peters; A C Issekutz
Journal: Agents Actions Date: 1993-11

10. Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses.

Authors: B Czarnetzki
Journal: Clin Exp Immunol Date: 1983-11 Impact factor: 4.330

10 in total